These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 26803423)

  • 1. Bioresorbable Scaffold Failure Due to Chronic Recoil in a Myocardial Bridge.
    Giavarini A; Longo G; Chen J; Rodríguez R; Di Mario C
    JACC Cardiovasc Interv; 2016 Mar; 9(6):e49-51. PubMed ID: 26803423
    [No Abstract]   [Full Text] [Related]  

  • 2. Restenosis in a Collapsed Magnesium Bioresorbable Scaffold.
    Barkholt TØ; Neghabat O; Terkelsen CJ; Christiansen EH; Holm NR
    Circ Cardiovasc Interv; 2017 Oct; 10(10):. PubMed ID: 29042399
    [No Abstract]   [Full Text] [Related]  

  • 3. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 4. Paclitaxel crystals on the surface of a bioresorbable vascular scaffold visualized by optical coherence tomography after drug-eluting balloon angioplasty.
    López-Benito M; Pérez de Prado A; Cuellas C; Estévez R; Fernández-Vázquez F
    Eur Heart J Cardiovasc Imaging; 2017 Jun; 18(6):638. PubMed ID: 28329070
    [No Abstract]   [Full Text] [Related]  

  • 5. Unfavorable bioresorbable vascular scaffold resorption, a cause of restenosis?
    Ishida K; Giacchi G; Brugaletta S; García-Álvarez A; Sabaté M
    Cardiovasc Revasc Med; 2016 Dec; 17(8):571-573. PubMed ID: 27345841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
    Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
    Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
    [No Abstract]   [Full Text] [Related]  

  • 7. Very late bioresorbable vascular scaffold thrombosis due to late device recoil.
    Cortese B; Piraino D; Ielasi A; Steffenino G; Orrego PS
    Int J Cardiol; 2015; 189():132-3. PubMed ID: 25889443
    [No Abstract]   [Full Text] [Related]  

  • 8. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 9. Early collapse causing stenosis in a resorbable magnesium scaffold.
    Marynissen T; McCutcheon K; Bennett J
    Catheter Cardiovasc Interv; 2018 Aug; 92(2):310-312. PubMed ID: 30019823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold.
    Mangiameli A; Ohno Y; Attizzani GF; Capodanno D; Tamburino C
    JACC Cardiovasc Interv; 2015 Apr; 8(4):633-4. PubMed ID: 25819179
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe focal restenosis 15 months after implantation of a magnesium bioresorbable scaffold.
    McCutcheon K; Bennett J; Marynissen T; Adriaenssens T
    Acta Cardiol; 2020 Feb; 75(1):85-86. PubMed ID: 30735472
    [No Abstract]   [Full Text] [Related]  

  • 12. Bioresorbable vascular scaffold restenosis: intravascular imaging evaluation.
    Fabris E; Kilic ID; Caiazzo G; Serdoz R; Foin N; Sinagra G; Di Mario C
    J Cardiovasc Med (Hagerstown); 2016 Dec; 17 Suppl 2():e132-e135. PubMed ID: 26599682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of acute scaffold recoil after implantation of the everolimus-eluting bioresorbable scaffold: an optical coherence tomography assessment in native coronary arteries.
    Sato T; Jose J; El-Mawardy M; Sulimov DS; Tölg R; Richardt G; Abdel-Wahab M
    Int J Cardiovasc Imaging; 2017 Feb; 33(2):145-152. PubMed ID: 27761749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
    Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
    Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary Artery Aneurysm After Bioresorbable Vascular Scaffold Implantation With Post-Dilation: Is Less More?
    Meincke F; Reinholz C; Spangenberg T; Wienemann H; Arjomand A; Kreidel F; Kuck KH; Ghanem A
    JACC Cardiovasc Interv; 2017 Jan; 10(1):96-97. PubMed ID: 28017314
    [No Abstract]   [Full Text] [Related]  

  • 16. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 17. Disruption of bioresorbable vascular scaffold struts due to loss of radial integrity: insights from optical coherence tomography.
    Ramalho AR; Silva Marques J; Mariano Pêgo G
    Int J Cardiovasc Imaging; 2017 Mar; 33(3):311-312. PubMed ID: 27832420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stentablation of an underexpanded stent in a heavily calcified lesion using rotational atherectomy.
    Lee S; Park KW; Kim HS
    J Cardiovasc Med (Hagerstown); 2012 Apr; 13(4):284-8. PubMed ID: 20489653
    [No Abstract]   [Full Text] [Related]  

  • 19. Coronary stent fracture: the hidden truth of a problem more common than stent thrombosis.
    Carroll JD
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):88-9. PubMed ID: 19089948
    [No Abstract]   [Full Text] [Related]  

  • 20. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.